Peterson Kristine
- SEC CIK
- 0001508596
No open-market purchases or sales filed in the past year.
Current role at each company
- AVBP ArriVent BioPharma, Inc.Directoras of Jun 22, 2026
- IMCR Immunocore Holdings plcDirectoras of May 28, 2026
- ENTA Enanta Pharmaceuticals IncDirectoras of Mar 13, 2026
- IMGN ImmunoGen, Inc.Directoras of Feb 12, 2024
- PRTK Paratek Pharmaceuticals, Inc.Directoras of Sep 21, 2023
Show 1 more company
- AMRN Amarin Corp PLCDirectoras of Jun 29, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Peterson Kristine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMGN ImmunoGen, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 (view filing) | Nov 30 | 5 daysLate | Peterson KristineDirector | SSale | −20.0K | $28.90 | −$578.0K | −100.0%0 after | 10b5-1 |